#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Homocystinuria Ischaemic stroke Retinal dystrophy Follicle centre lymphoma follicular grade I II – III refractory Breast angiosarcoma Neuroendocrine carcinoma of the skin Extranodal marginal zone B-cell lymphoma (MALT type) Progressive familial intrahepatic cholestasis Pericarditis Hereditary neuropathic amyloidosis Adenovirus infection Small intestine neuroendocrine tumour Sexually transmitted disease Osteosarcoma metastatic Scleroderma associated digital ulcer More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Diagnostics Ewing’s sarcoma recurrent – Diagnostics Glomerulonephritis rapidly progressive – Trials in Disease MELAS syndrome Inclusion body myositis – Diagnostics Idiopathic pulmonary fibrosis – Life with Disease Nephrotic syndrome – Basic Information Pulmonary sarcoidosis Methylmalonic acidaemia – Basic Information Sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nemolizumab LIPASE Elenestinib Phosphate Rbl035.2 Thalidomide Dopamine Hydrochloride Pseudoephedrine Hydrochloride Etoposide Phosphate Cabozantinib Gadobenate Dimeglumine Asfotase Alfa Desonide Sodium 2-Hydroxylinoleate CYCLIZINE HYDROCHLORIDE OSIMERTINIB MESYLATE GSKVX000000070248 Diphenhydramine Hydrochloride Fondaparinux Sodium Arrhenatherum Elatius Mecillinam More therapies…

    Learn about Your Condition

    Biliary cancer metastatic Psoriasis Tendon injury Cholangiosarcoma Breast cancer metastatic Pelizaeus-Merzbacher disease Muscle spasticity Benign renal neoplasm Turner's syndrome Ehlers-Danlos syndrome Infectious pleural effusion Bacterial prostatitis Pseudomonas infection Cholangitis sclerosing Primary hyperaldosteronism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rectal cancer stage II

  • Study comparing treatment with or without tislelizumab for patients with locally advanced rectal cancer to see if surgery can be avoided

    Recruiting

    2 1 1
    Investigated Diseases:
    • Rectal cancer stage II
    • Rectal cancer stage III
    Investigated Drugs:
    • Tislelizumab
    Germany

  • Study Comparing Short-Course Radiotherapy and Drug Combination for Older Patients with Locally Advanced Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metoclopramide
    • Capecitabine
    • Dexamethasone
    Belgium

  • Study of Regorafenib and Nivolumab with radiotherapy for patients with stage II-III rectal cancer before surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer stage II
    • Rectal cancer stage III
    Investigated Drugs:
    • Regorafenib
    • Nivolumab
    Belgium

  • Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Rectal cancer stage II
    Investigated Drugs:
    • Capecitabine
    Austria Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!